A liver transplant recipient was reinfected with SARS-CoV-2 111 days after his initial diagnosis. Researchers from the University of Massachusetts Medical School and The Broad Institute of MIT and Harvard used viral genomic sequencing to distinguish whether the later positive samples were due to SARS-CoV-2 relapse or reinfection. The case report is published in
Annals of Internal Medicine.
A 61-year-old man with a history of liver transplant reported to the emergency department (ED) complaining of fever, nausea, vomiting, and cough. The patient tested positive for SARS-CoV-2 infection with a RT-qPCR swab taken at the time of his visit. Swabs taken 48 and 53 days after his visit were negative for the virus. On day 111, the patient returned to the ED reporting several days of increasing confusion, hallucinations, unstable gait, and frequent falls. Once again, the patient tested positive for SARS-CoV-2 infection.
Share this article
Share this article
PASADENA, Calif., April 15, 2021 /PRNewswire/ The numbers of recommended vaccine doses, including measles vaccine, administered to children decreased dramatically after the declaration of a national state of emergency on March 13, 2020, due to the COVID-19 pandemic, according to a Kaiser Permanente study published in Pediatrics. While the decrease was lower and recovered in children under 2 years of age, it was more severe and persistent in older children. When vaccination rates decline, we worry about an increase in vaccine-preventable diseases that can be harmful to children, said the study s lead author, Bradley Ackerson, MD, a Kaiser Permanente South Bay Medical Center pediatric infectious disease specialist and an investigator with the Kaiser Permanente Southern California Department of Research & Evaluation s vaccine team. Also, we know there has been a reduction in childhood vaccinations worldwide, and as COVID-19 restrictions are
Child vaccination rates declined during COVID-19 pandemic apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
PASADENA, Calif., March 10, 2021 /PRNewswire/ A Kaiser Permanente study showed that one type of pneumonia vaccine, the PCV13 vaccine, may affect the course of COVID-19 for some older adult patients. The study was published in The Journal of Infectious Diseases. Kaiser Permanente members who received the PCV13 vaccine appeared to be diagnosed with COVID-19 less often, and when they were, they seemed to have less severe outcomes, overall, said the senior author, Sara Y. Tartof, PhD, MPH, a scientist with the Kaiser Permanente Southern California Department of Research & Evaluation. One of the most interesting aspects of our findings was that the patients who received PCV13 received some protection against COVID-19, while those who received PPSV23, another pneumococcal vaccine, did not.
Trial compares two gestational diabetes screening methods apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.